Evidence map›Paper›PMID 20140521›Full record

ReviewApoptosis : an international journal on programmed cell death2010

Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells.

Adrian E Morelli, Adriana T Larregina

Open access · hybridAbstract readReview
In one paragraph

Review in Apoptosis : an international journal on programmed cell death, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 69 citations in OpenAlex.

  1. Trial
  2. Article
  3. Apoptotic Donor Cells in Transplantation.Frontiers in immunology · 2021
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. "Eat me" imaging and therapy.Advanced drug delivery reviews · 2016
    Review
  13. Article
  14. Review
  15. Review
  16. Death-defining immune responses after apoptosis.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2014
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Adrian E MorelliT.E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, PA 15213-2582, USA. morelli@imap.pitt.edu
Adriana T Larregina
University of Pittsburgh Medical Center · US

Funding

Use of Substance P antagonists to regulate the skin immune functionR01AI077511 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LARREGINA, ADRIANA T · 2009 to 2013
$1.8M
Graft Tolerance with Apoptotic Cells and Dendritic CellsR01HL077545 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MORELLI, ADRIAN E. · 2005 to 2008
$1.4M
Use of Adjuvants to Improve Skin Genetic ImmunizationsR01CA100893 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LARREGINA, ADRIANA T · 2004 to 2008
$1.3M
NCI NIH HHS R01 CA100893NHLBI NIH HHS R01 HL077545NIAID NIH HHS R01 AI077511
6 · The paper itself

Abstract

One of the ultimate goals in transplantation is to develop novel therapeutic methods for induction of donor-specific tolerance to reduce the side effects caused by the generalized immunosuppression associated to the currently used pharmacologic regimens. Interaction or phagocytosis of cells in early apoptosis exerts potent anti-inflammatory and immunosuppressive effects on antigen (Ag)-presenting cells (APC) like dendritic cells (DC) and macrophages. This observation led to the idea that apoptotic cell-based therapies could be employed to deliver donor-Ag in combination with regulatory signals to recipient's APC as therapeutic approach to restrain the anti-donor response. This review describes the multiple mechanisms by which apoptotic cells down-modulate the immuno-stimulatory and pro-inflammatory functions of DC and macrophages, and the role of the interaction between apoptotic cells and APC in self-tolerance and in apoptotic cell-based therapies to prevent/treat allograft rejection and graft-versus-host disease in murine experimental systems and in humans. It also explores the role that in vivo-generated apoptotic cells could have in the beneficial effects of extracorporeal photopheresis, donor-specific transfusion, and tolerogenic DC-based therapies in transplantation.

Indexed as

ApoptosisCell TransplantationGraft RejectionImmunosuppression TherapyAnimalsCell- and Tissue-Based TherapyDendritic CellsGraft vs Host DiseaseHumansMice

Identifiers

PMID20140521
PMCPMC2929431
OpenAlexW2045847416

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.